ASND · Ascendis Pharma A/S · Documents

$234.33 +4.38 (+1.90%) At close · Oct 20

Market Cap

$15.39B

65.80M

Volume · Oct 20 394.83K Avg daily vol (3M) 686.74K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2021-04-30	—
6-K	—	2021-04-15	2021-04-14
6-K	—	2021-04-01	2021-03-31
6-K	—	2021-03-10	—
20-F	—	2021-03-10	2020-12-31
6-K	—	2021-03-09	—
6-K	—	2021-02-11	2021-02-10
6-K	—	2021-01-13	—
6-K	—	2021-01-11	—
6-K	—	2021-01-11	2021-01-08
6-K	—	2020-12-31	2020-12-30
6-K	—	2020-12-30	—
6-K	—	2020-12-14	—
6-K	—	2020-12-11	—
6-K	—	2020-11-20	—
6-K	—	2020-11-12	—
6-K	—	2020-11-12	—
6-K	—	2020-10-23	2020-10-22
6-K	—	2020-10-16	2020-10-14
6-K	—	2020-10-05	—
6-K	—	2020-09-29	—
6-K	—	2020-09-29	—
6-K	—	2020-09-23	—
6-K	—	2020-09-10	—
6-K	—	2020-09-08	—
6-K	—	2020-08-27	—
6-K	—	2020-08-13	2020-08-12
6-K	—	2020-07-17	2020-07-15
6-K	—	2020-07-10	—
6-K	—	2020-07-06	—
6-K	—	2020-07-01	—
6-K	—	2020-06-26	2020-06-25
6-K	—	2020-06-12	2020-06-10
6-K	—	2020-06-01	2020-05-31
6-K	—	2020-05-19	—
6-K	—	2020-05-15	2020-05-13
6-K	—	2020-05-05	—
6-K	—	2020-04-30	2020-04-29
6-K	—	2020-04-20	—
6-K	—	2020-04-20	—
6-K	—	2020-04-15	—
20-F	—	2020-04-03	2019-12-31
6-K	—	2020-04-01	—
6-K	—	2020-03-31	—
6-K	—	2020-03-12	2020-03-11
6-K	—	2020-02-12	—
6-K	—	2020-01-15	—
6-K	—	2020-01-13	—
6-K	—	2020-01-06	2019-12-31

Showing 251–299 of 299 filings

Key facts CIK 1612042 CUSIP K08588103 13F (30d) 27 filings 27 filers Visit website Investor relations